Published in Horm Metab Res on January 01, 2005
Characteristics of membrane progestin receptor alpha (mPRalpha) and progesterone membrane receptor component 1 (PGMRC1) and their roles in mediating rapid progestin actions. Front Neuroendocrinol (2008) 1.60
Minireview: Recent advances in extranuclear steroid receptor actions. Endocrinology (2011) 1.20
Rapid signaling by steroid receptors. Am J Physiol Regul Integr Comp Physiol (2008) 1.18
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway. Breast Cancer Res (2010) 1.03
Progesterone regulation of progesterone receptor membrane component 1 (PGRMC1) sumoylation and transcriptional activity in spontaneously immortalized granulosa cells. Endocrinology (2012) 0.94
Non-canonical progesterone signaling in granulosa cell function. Reproduction (2014) 0.91
Novel progesterone receptors: neural localization and possible functions. Front Neurosci (2013) 0.89
Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B). Mol Cancer (2010) 0.81
Broad tissue expression of membrane progesterone receptor Alpha in normal mice. J Mol Histol (2010) 0.81
Cloning, mapping and molecular characterization of porcine progesterone receptor membrane component 2 (PGRMC2) gene. Genet Mol Biol (2010) 0.81
Membrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective study. PLoS One (2012) 0.81
Two unrelated putative membrane-bound progestin receptors, progesterone membrane receptor component 1 (PGMRC1) and membrane progestin receptor (mPR) beta, are expressed in the rainbow trout oocyte and exhibit similar ovarian expression patterns. Reprod Biol Endocrinol (2006) 0.78
Expression of nuclear progesterone receptor and progesterone receptor membrane components 1 and 2 in the oviduct of cyclic and pregnant cows during the post-ovulation period. Reprod Biol Endocrinol (2012) 0.78
Evidence for the participation of calcium in non-genomic relaxations induced by androgenic steroids in rat vas deferens. Br J Pharmacol (2008) 0.77
Expression of a mitochondrial progesterone receptor in human spermatozoa correlates with a progestin-dependent increase in mitochondrial membrane potential. Andrology (2014) 0.76
Progesterone and Src family inhibitor PP1 synergistically inhibit cell migration and invasion of human basal phenotype breast cancer cells. Biomed Res Int (2015) 0.76
Multiple actions of steroid hormones--a focus on rapid, nongenomic effects. Pharmacol Rev (2000) 2.94
Attenuation of heart-rate variability in postmenopausal women on progestin-containing hormone replacement therapy. Lancet (1999) 1.98
A new hypothesis of modular glucocorticoid actions: steroid treatment of rheumatic diseases revisited. Arthritis Rheum (1998) 1.90
Purification and partial sequencing of high-affinity progesterone-binding site(s) from porcine liver membranes. Eur J Biochem (1996) 1.70
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. Int Angiol (2012) 1.60
Dominant negative myostatin produces hypertrophy without hyperplasia in muscle. FEBS Lett (2000) 1.50
Cloning and tissue expression of two putative steroid membrane receptors. Biol Chem (1998) 1.48
Mechanical loading regulates NOS expression and activity in developing and adult skeletal muscle. Am J Physiol (1998) 1.46
Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem Biophys Res Commun (1996) 1.40
[Prevention of adverse drug reactions in older patients]. Z Gerontol Geriatr (2007) 1.27
Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo. J Neurosci (2000) 1.20
The binding of drugs to different polar lipids in vitro. Biochem Pharmacol (1979) 1.14
Rapid, nongenomic steroid actions: A new age? Front Neuroendocrinol (2000) 1.09
Specific progesterone binding to a membrane protein and related nongenomic effects on Ca2+-fluxes in sperm. Endocrinology (1999) 1.07
Mesial temporal spikes interfere with working memory. Neurology (1997) 1.03
Mannheim classification of nongenomically initiated (rapid) steroid action(s). J Clin Endocrinol Metab (2000) 0.98
Chemical modification and structural analysis of the progesterone membrane binding protein from porcine liver membranes. Mol Cell Biochem (2001) 0.98
Nongenomically initiated steroid actions. Eur J Clin Invest (2000) 0.95
Rapid nongenomic effects of aldosterone in mineralocorticoid-receptor-knockout mice. Biochem Biophys Res Commun (1999) 0.95
Alterations in platelet function during the ovarian cycle. Blood Coagul Fibrinolysis (2002) 0.95
Characterization of high affinity progesterone-binding membrane proteins by anti-peptide antiserum. Steroids (1998) 0.91
Comparison of the mechanisms of nongenomic actions of thyroid hormone and steroid hormones. J Endocrinol Invest (2002) 0.91
Rapid aldosterone signaling in vascular smooth muscle cells: involvement of phospholipase C, diacylglycerol and protein kinase C alpha. Biochem Biophys Res Commun (1995) 0.91
The human membrane progesterone receptor gene: genomic structure and promoter analysis. DNA Seq (2001) 0.90
Localization of a putative progesterone membrane binding protein in porcine hepatocytes. Cell Mol Biol (Noisy-le-grand) (1998) 0.89
Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family? Eur J Pharmacol (1998) 0.89
Effects of progestin-estrogen replacement therapy on QT-dispersion in postmenopausal women. Int J Cardiol (2000) 0.88
Rapid effects of aldosterone on sodium transport in vascular smooth muscle cells. Hypertension (1995) 0.88
Striking increase of natriuresis by low-dose spironolactone in congestive heart failure only in combination with ACE inhibition: mechanistic evidence to support RALES. Circulation (2000) 0.87
Effect of oral contraceptives and ovarian cycle on platelet function. Platelets (2007) 0.86
The inositol-1,4,5-trisphosphate system is involved in rapid effects of aldosterone in human mononuclear leukocytes. J Clin Endocrinol Metab (1993) 0.86
Aldosterone, not estradiol, is the physiological agonist for rapid increases in cAMP in vascular smooth muscle cells. Circulation (1999) 0.86
Nitric-oxide synthase is a mechanical signal transducer that modulates talin and vinculin expression. J Biol Chem (1999) 0.85
Specific nongenomic actions of aldosterone. Kidney Int (2000) 0.85
Interaction of rapid nongenomic cardiovascular aldosterone effects with the adrenergic system. J Clin Endocrinol Metab (2001) 0.84
The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. J Clin Pharmacol (1999) 0.84
Short term cardiovascular effects of aldosterone in healthy male volunteers. J Clin Endocrinol Metab (1999) 0.83
Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells. Am J Physiol (1997) 0.83
Effects of potassium lactate, sodium chloride, and sodium acetate on surface shininess/gloss and sensory properties of injection-enhanced beef strip-loin steaks. Meat Sci (2006) 0.83
Novel membrane receptors for aldosterone in human lymphocytes: a 50 kDa protein on SDS-PAGE. Cell Mol Biol (Noisy-le-grand) (1994) 0.82
Improving the health care of geriatric patients: management of urinary incontinence: a position paper. Z Gerontol Geriatr (2013) 0.82
[Difficulties in pharmacotherapy of the elderly]. Internist (Berl) (2010) 0.81
Cardiovascular steroid actions: swift swallows or sluggish snails? Cardiovasc Res (1998) 0.81
Safety of low-density lipoprotein cholestrol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial). Am J Cardiol (1999) 0.81
Aneurysms of coronary arteries in a patient with adult polycystic kidney disease: arteriosclerosis or involvement by the primary disease? Clin Investig (1993) 0.81
Compatibility of plastics with cytotoxic drug solutions-comparison of polyethylene with other container materials. Int J Pharm (1999) 0.81
Delayed genomic and acute nongenomic action of glucocorticosteroids in seasonal allergic rhinitis. Eur J Clin Invest (2004) 0.81
Effects of potassium lactate, sodium chloride, sodium tripolyphosphate, and sodium acetate on colour, colour stability, and oxidative properties of injection-enhanced beef rib steaks. Meat Sci (2006) 0.81
Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism. Exp Clin Endocrinol Diabetes (2005) 0.80
[Pharmacotherapy of elderly patients]. Internist (Berl) (2007) 0.79
Characterization and solubilization of novel aldosterone-binding proteins in porcine liver microsomes. Eur J Biochem (1995) 0.79
Interaction of chlormadinone acetate with the ouabain binding site of Na+,K+-ATPase. Mol Pharmacol (1981) 0.79
Recognition of a human sperm surface protein involved in the progesterone-initiated acrosome reaction by antisera against an endomembrane progesterone binding protein from porcine liver. Mol Cell Endocrinol (1999) 0.79
Coagulation status in coronary artery disease patients with type II diabetes mellitus compared with non-diabetic coronary artery disease patients using the PFA-100® and ROTEM®. Platelets (2010) 0.79
Lipid-lowering medication for secondary prevention of coronary heart disease in a German outpatient population: the gap between treatment guidelines and real life treatment patterns. Prev Med (2002) 0.78
Nongenomic steroid actions: fact or fantasy? Vitam Horm (1999) 0.78
Rapid aldosterone effects on tyrosine phosphorylation in vascular smooth muscle cells. Cell Mol Biol (Noisy-le-grand) (1999) 0.78
Effect of aldosterone on sodium and potassium concentrations in human mononuclear leukocytes. Am J Physiol (1987) 0.78
Angiotensin II binding to human mononuclear cells: receptor or free fluid endocytosis? Clin Sci (Lond) (1984) 0.78
Influence of aldosterone vs. endothelin receptor antagonism on renovascular function in liquorice-induced hypertension. Nephrol Dial Transplant (2001) 0.78
Assuming the worst may not be bad at all. Carvedilol in heart failure treatment. Eur J Clin Pharmacol (1998) 0.78
[Anticoagulation in the elderly]. Internist (Berl) (2010) 0.78
Simultaneous assay of morphine, morphine-3-glucuronide and morphine-6-glucuronide in human plasma using normal-phase liquid chromatography-tandem mass spectrometry with a silica column and an aqueous organic mobile phase. J Chromatogr B Biomed Sci Appl (1999) 0.77
[Assessment of drug treatment in geriatrics with the new FORTA criteria]. Dtsch Med Wochenschr (2011) 0.77
Impact of plasmapheresis on platelet hemostatic capacity in healthy voluntary blood donors detected by the platelet function analyzer PFA-100. Platelets (2001) 0.77
Non-classical receptors for aldosterone in plasma membranes from pig kidneys. Mol Cell Endocrinol (1994) 0.77
Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells. Steroids (1999) 0.77
[The relative bioavailability and pharmacokinetics of chloral hydrate and its metabolites]. Arzneimittelforschung (1998) 0.77
Nongenomic steroid actions: completing the puzzle. Aldosterone as an example. Exp Clin Endocrinol Diabetes (1998) 0.77
Diabetes and cardiovascular risk evaluation and management in primary care: progress and unresolved issues - rationale for a nationwide primary care project in Germany. Exp Clin Endocrinol Diabetes (2004) 0.77
Determination of xanthine oxidoreductase activity in broilers: effect of pH and temperature of the assay and distribution in tissues. Poult Sci (2009) 0.77
The PFA-100R cannot detect blood group-dependent inhibition of platelet function by eptifibatide or abciximab at therapeutic plasma concentrations. Platelets (2010) 0.77
Aldosterone- and progesterone-membrane-binding proteins: new concepts of nongenomic steroid action. Curr Protein Pept Sci (2000) 0.77
Long-term effect of captopril on kidney function in various forms of hypertension. Klin Wochenschr (1984) 0.76
Seminal plasma hormone concentration after oral application of progesterone. Int J Clin Pharmacol Ther (2002) 0.76
Heart rate variability and hormone replacement therapy. Lancet (1999) 0.76
Nongenomic effects of aldosterone on human renal cells. J Clin Endocrinol Metab (2003) 0.76
Nongenomic actions of steroids--from the laboratory to clinical implications. J Pediatr Endocrinol Metab (2000) 0.76
Anticoagulation in patients with impaired renal function and with haemodialysis. Anticoagulant effects, efficacy, safety, therapeutic options. Hamostaseologie (2014) 0.76
Mineralocorticoid effector mechanism of liquorice derivatives in human mononuclear leukocytes. J Endocrinol Invest (1989) 0.76
Impact of ABO blood groups on tirofiban mediated inhibition of platelet function. Platelets (2005) 0.76
[Optimal stroke prevention in the geriatric patient with atrial fibrillation: position paper of an interdisciplinary expert panel]. MMW Fortschr Med (2014) 0.76
Clonidine through the skin in the treatment of essential hypertension: is it practical? J Hypertens Suppl (1983) 0.75
The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol (2001) 0.75
Inhibition of platelet aggregation after intake of acetylsalicylic acid detected by a platelet function analyzer (PFA-100). Int J Clin Pharmacol Ther (1999) 0.75
Biotin-labelled and photoactivatable aldosterone and progesterone derivatives as ligands for affinity chromatography, fluorescence immunoassays and photoaffinity labelling. Eur J Biochem (1996) 0.75
[Commentary on the ALLHAT study. Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial]. Dtsch Med Wochenschr (2003) 0.75